Shanghai Haohai Biological Technology Co., Ltd (6826.HK) reported earnings for full year that Dropped, from the same period last year
The company's bottom line came in at RMB251.01 million, or RMB1.08 per share. This compares with RMB420.45 million, or RMB1.80 per share, last year.
The company's revenue for the period fell 8.7% to RMB2.446 billion from RMB2.679 billion last year.
Shanghai Haohai Biological Technology Co., Ltd earnings at a glance (GAAP) :
-Earnings: RMB251.01 Mln. vs. RMB420.45 Mln. last year.-EPS: RMB1.08 vs. RMB1.80 last year.-Revenue: RMB2.446 Bln vs. RMB2.679 Bln last year.
For comments and feedback contact: editorial@rttnews.com
May 08, 2026 15:50 ET Manufacturing and services sector survey results and labor market data from main economies were the highlight on the economics news front this week. Factory orders and jobs report dominated the news flow in the U.S. Similarly, industrial production data from German garnered attention in Europe. In Asia, purchasing managers’ survey results from China and the central bank decision from Australia were in focus.